Akums Subsidiary Acquires Oriflame India Mfg Business for ₹56 Cr

Akums Drugs and Pharmaceuticals Ltd, through its wholly-owned subsidiary Pure and Cure Healthcare Private Limited, has approved the acquisition of Oriflame India Private Limited's manufacturing business for a total consideration of INR 56 Crore. The deal includes two manufacturing plants in Roorkee and Noida, along with a leased warehouse in Noida. This acquisition marks Akums' entry into color cosmetics and expands its presence in skincare and wellness products. The trademark and marketing of Oriflame's products in India are excluded from this transaction. The acquisition is expected to be completed by August 31, 2026, and no prior governmental or regulatory approvals are required.